We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cannabis Industry to Scale New Highs Amid Legalization Woes
Read MoreHide Full Article
Legalization of cannabis is the most discussed topic at present. The move is likely to boost the cannabis market as well as increase its popularity and distribution over the next few years. However, concerns over legalization persist.
Research reveals that the cannabis industry in the United States is slated to rise at a double-digit clip. Per New Frontier Data, total legal cannabis sales in the states that have legalized cannabis is expected to witness growth at 14% compound annual growth rate (CAGR) over the next six years and reach $30 billion by 2025.
The report shows that there is immense potential in the untapped legal cannabis industry. While annual revenues from medical cannabis is expected to grow at a 17% CAGR through 2025, sales from adult-use are forecast to reach $16.6 billion, growing at a CAGR of 16%. Therefore, the hemp stocks likely to benefit from legalization.
Currently, medical use of cannabis is legal in 33 states. Moreover, 11 states as well as Washington DC have legalized its recreational use.
President Trump has reiterated that his administration will enable the states to legalize the use of cannabis. Further legalization of cannabis is likely to drive its commercial distribution and boost growth of companies operating in this space, including Aurora Cannabis Inc. (ACB - Free Report) , Cronos Group Inc. (CRON - Free Report) and Canopy Growth Corporation (CGC - Free Report) . The companies have a combined market cap of around $17 billion.
Our 3 Top Picks
Given the significant growth opportunities in the cannabis market over the next few years, we have short-listed some top-ranked players in the space. These companies are likely to benefit from positive developments in the cannabis industry. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
GW Pharmaceuticals plc discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
The company has a market cap of roughly $3.9 billion and sports a Zacks Rank #1. The Zacks Consensus Estimate for the current year has moved up 91.1% in the past 60 days. The company’s shares have also rallied 32.3% year to date.
The Scotts Miracle-Gro Company (SMG - Free Report) is one of the largest marketers of branded consumer products for lawn as well as garden care in the world. Its fully-owned subsidiary, Hawthorne Gardening Company, is a leading provider of lighting, nutrients and other materials used in the hydroponic growing segment.
The company has a market cap of $5.6 billion and also flaunts a Zacks Rank #1. The Zacks Consensus Estimate for the current fiscal has moved up 3.9% in the past 60 days. The company’s shares have surged 63% year to date.
Innovative Industrial Properties, Inc. (IIPR - Free Report) is focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
The company has a market cap of around $1.1 billion and carries a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for the current year has moved up 2% in the past 60 days. The company’s shares have skyrocketed 114.4% year to date.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Cannabis Industry to Scale New Highs Amid Legalization Woes
Legalization of cannabis is the most discussed topic at present. The move is likely to boost the cannabis market as well as increase its popularity and distribution over the next few years. However, concerns over legalization persist.
Research reveals that the cannabis industry in the United States is slated to rise at a double-digit clip. Per New Frontier Data, total legal cannabis sales in the states that have legalized cannabis is expected to witness growth at 14% compound annual growth rate (CAGR) over the next six years and reach $30 billion by 2025.
The report shows that there is immense potential in the untapped legal cannabis industry. While annual revenues from medical cannabis is expected to grow at a 17% CAGR through 2025, sales from adult-use are forecast to reach $16.6 billion, growing at a CAGR of 16%. Therefore, the hemp stocks likely to benefit from legalization.
Currently, medical use of cannabis is legal in 33 states. Moreover, 11 states as well as Washington DC have legalized its recreational use.
President Trump has reiterated that his administration will enable the states to legalize the use of cannabis. Further legalization of cannabis is likely to drive its commercial distribution and boost growth of companies operating in this space, including Aurora Cannabis Inc. (ACB - Free Report) , Cronos Group Inc. (CRON - Free Report) and Canopy Growth Corporation (CGC - Free Report) . The companies have a combined market cap of around $17 billion.
Our 3 Top Picks
Given the significant growth opportunities in the cannabis market over the next few years, we have short-listed some top-ranked players in the space. These companies are likely to benefit from positive developments in the cannabis industry. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
GW Pharmaceuticals plc discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
The company has a market cap of roughly $3.9 billion and sports a Zacks Rank #1. The Zacks Consensus Estimate for the current year has moved up 91.1% in the past 60 days. The company’s shares have also rallied 32.3% year to date.
The Scotts Miracle-Gro Company (SMG - Free Report) is one of the largest marketers of branded consumer products for lawn as well as garden care in the world. Its fully-owned subsidiary, Hawthorne Gardening Company, is a leading provider of lighting, nutrients and other materials used in the hydroponic growing segment.
The company has a market cap of $5.6 billion and also flaunts a Zacks Rank #1. The Zacks Consensus Estimate for the current fiscal has moved up 3.9% in the past 60 days. The company’s shares have surged 63% year to date.
Innovative Industrial Properties, Inc. (IIPR - Free Report) is focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
The company has a market cap of around $1.1 billion and carries a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for the current year has moved up 2% in the past 60 days. The company’s shares have skyrocketed 114.4% year to date.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>